Gfi235 -Erratum
Irbesartan reduces creatinine clearance in type 1 diabetic children with renal hyperfunction: a randomized, double-blind, placebo-controlled trial Mario R Salcedo-Alejos, Felipe Banda-Espinoza, Martha Rodrı´guez-Mora´n and Fernando Guerrero-Romero* In the second paragraph, line 7, the passage ' . . . if they had renal hyperfunction, defined as a CCR>20 ml/min/ 1.73 m 2 body surface area' should read ' . . . if they had renal hyperfunction, defined as a CCR>120 ml/min/ 1.73 m 2 body surface area'. The complete and correct passage is below:
Children were eligible to participate if they had renal hyperfunction, defined as a CCR>120 ml/min/1.73 m 2 body surface area, published in the October 2005 issue of Nephrology Dialysis Transplantation.
The authors would like to apologise for this error.
